Amphastar Pharmaceuticals, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AMPH research report →
Companywww.amphastar.com
Amphastar Pharmaceuticals, Inc. , a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API.
- CEO
- Yongfeng Zhang
- IPO
- 2014
- Employees
- 2,028
- HQ
- Rancho Cucamonga, CA, US
Price Chart
Valuation
- Market Cap
- $797.20M
- P/E
- 10.34
- P/S
- 1.11
- P/B
- 1.06
- EV/EBITDA
- 8.42
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 47.34%
- Op Margin
- 16.20%
- Net Margin
- 11.00%
- ROE
- 10.23%
- ROIC
- 6.02%
Growth & Income
- Revenue
- $719.89M · -1.65%
- Net Income
- $98.09M · -38.51%
- EPS
- $2.10 · -36.17%
- Op Income
- $140.40M
- FCF YoY
- -29.66%
Performance & Tape
- 52W High
- $31.26
- 52W Low
- $16.65
- 50D MA
- $20.24
- 200D MA
- $24.96
- Beta
- 0.97
- Avg Volume
- 617.18K
Get TickerSpark's AI analysis on AMPH
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 15, 26 | Liawatidewi Yakob | other | 1,033 |
| Mar 15, 26 | Zhou Rong | other | 1,225 |
| Mar 15, 26 | PETERS WILLIAM J | other | 1,973 |
| Mar 15, 26 | Zhang Jack Y. | other | 9,784 |
| Mar 15, 26 | Zhang Jack Y. | other | 2,908 |
| Mar 9, 26 | PETERS WILLIAM J | other | 58,693 |
| Mar 10, 26 | PETERS WILLIAM J | other | 3,297 |
| Mar 9, 26 | PETERS WILLIAM J | other | 121,071 |
| Mar 9, 26 | Zhou Rong | other | 39,432 |
| Mar 10, 26 | Zhou Rong | other | 2,215 |
Our AMPH Coverage
We haven't published any research on AMPH yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AMPH Report →